Turkish Affordances in the Home Environment for Motor Development-Infant Scale (AHEMD-IS)

NCT ID: NCT04556487

Last Updated: 2023-03-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

139 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-10-01

Study Completion Date

2023-02-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Environment which children live and grown is very important for the all development stages. In Turkey there is no measurement for home environment evaluation so our aim is to investigate the Psychometric Properties of the Turkish version of Affordances in the Home Environment for Motor Development-Infant Scale (AHEMD-IS) in a sample of Turkısh children.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

With the advances in technology and medical fields, the rate of cerebral palsy is increasing worldwide with the increase in the survival rate of preterm, low birth weight babies and neurodevelopmentally risky babies living in neonatal intensive care units.

The International Classification of Health, Function and Disability - Child and Youth version (ICF-CY), developed by the World Health Organization, provides a common language to record problems involving functions and structures of the body, restrictions of activity and participation that occur in childhood and adolescence, and related environmental factors; and It was developed to use terminology and consists of four main components: "Body Functions", "Body Structures", "Activity and Participation", "Environmental Factors". According to ICF-CY, environmental factors that have an effect on activity and participation are changeable factors. Therefore, it is stated that environmental conditions should be changed, redesigned and the child-supportive environment should be increased in order to increase the level of activity and participation in children.

Preschool children spend most of their time at home and playing games. Toys in the game environment, playmates, parental participation and attitude play a major role in the development of the child's motor and cognitive skills and social participation (6, 7). In recent years, the importance and positive effects of the enriched environment on the motor and cognitive development of babies have been emphasized in studies. Regular neuromotor evaluations and follow-up of risky babies are guiding in establishing an early intervention program. The "Affordances in the Home Environment for Motor Development-Infant Scale (AHEMD-IS)" scale, developed to evaluate the characteristics of the environment in which babies live, is a valid and reliable scale that is frequently used in the literature in many different areas such as hearing loss, motor developmental delay, sensory impairment, and typical development. is a scale (8-11). Translation has been done in many different languages so far. Turkish infants at risk on a scale to evaluate the home environment in Turkey within our existing information is not yet available. It is thought that the introduction of the AHEMD-IS scale into the Turkish language will give clinicians and academicians a different perspective in the evaluation of risky babies and children.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Developmental Delay Disorder Genetic Disease Metabolic Disease Congenital Disorders Musculoskeletal Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

evaluation

we will evaluate the home environment of the children asking by parents

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Volunteer parents who have;
* 3-18 months child/children
* All children as typically developing children, genetic disorders, metabolic disorders, neuromotor disorders etc.

Exclusion Criteria

* Parents who refuse to participate in the study
Minimum Eligible Age

3 Months

Maximum Eligible Age

18 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hacettepe University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Özge ÇANKAYA

Principle investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Özge Çankaya, PhD

Role: PRINCIPAL_INVESTIGATOR

Hacettepe University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cumhuriyet University

Sivas, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

References

Explore related publications, articles, or registry entries linked to this study.

1. Eunson P. Aetiology and epidemiology of cerebral palsy. J Paediatr Child Health. 2012;22(9):361-6.

Reference Type BACKGROUND

2. World Health Organization. (2007). International Classification of Functioning, Disability, and Health: Children & Youth Version: ICF-CY. World Health Organization.

Reference Type BACKGROUND

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GO-2020

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pediatric Drug Application
NCT06836674 COMPLETED NA